Wuzhou Medical announced that shareholders Zhou Lexiang and Pan Lanlan completed their holdings reduction plan on December 15, 2025. Zhou Lexiang reduced his holdings by 127,500 shares through centralized bidding transactions, accounting for 0.1875% of the company's total share capital. The reduced price range was 38.2 yuan/share - 45.5 yuan/share; Pan Lanlan also reduced his holdings of 6,9050 shares through centralized bidding transactions, accounting for 0.1015% of the company's total share capital, and the reduced price range was 38.2 yuan/share - 45.5 yuan/share. After the holdings were reduced, Zhou Lexiang held 382,500 shares of the company, accounting for 0.5625% of the company's total share capital; Pan Lanlan held 2071,000 shares of the company, accounting for 0.3046% of the company's total share capital.

Wuzhou Medical announced that shareholders Zhou Lexiang and Pan Lanlan completed their holdings reduction plan on December 15, 2025. Zhou Lexiang reduced his holdings by 127,500 shares through centralized bidding transactions, accounting for 0.1875% of the company's total share capital. The reduced price range was 38.2 yuan/share - 45.5 yuan/share; Pan Lanlan also reduced his holdings of 6,9050 shares through centralized bidding transactions, accounting for 0.1015% of the company's total share capital, and the reduced price range was 38.2 yuan/share - 45.5 yuan/share. After the holdings were reduced, Zhou Lexiang held 382,500 shares of the company, accounting for 0.5625% of the company's total share capital; Pan Lanlan held 2071,000 shares of the company, accounting for 0.3046% of the company's total share capital.